Legal Representation
Attorney
Christiane S. Campbell
USPTO Deadlines
Next Deadline
45 days remaining
Non-Final Action Mailed
Due Date
December 17, 2025
Extension Available
Until March 17, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 17, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 17, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 17, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 3, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 3, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 30, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 30, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Apr 25, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Apr 25, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
Class 044
Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient’s white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Classification
International Classes
005
044